Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Gadolinium
Matrix: | Human Urine |
Assay Range: | 1.00 - 1,000 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Diagnostic |
Classification: | Drug Assays |
Galantamine
Matrix: | Human Plasma |
Assay Range: | 0.5 - 60 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Gamma-glutamyl Transferase activity
Matrix: | Human Urine |
Assay Range: | 4.00 - 40.0 nmol/L |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | 2 - 8 |
Platform: | Colorimetric |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Gemcitabine
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Gemcitabine
dFdU
dFdU
Matrix: | Human plasma |
Assay Range: | 0.1 - 50 ng/mL0.1 - 50 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Gemfibrozil
Matrix: | Human Plasma |
Assay Range: | 50 - 25,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Gemfibrozil
Matrix: | Human Plasma |
Assay Range: | 0.1 to 50 µg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Gemifloxacin
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Genfitinib
Matrix: | Human Plamsa |
Assay Range: | 0.5 -200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | K2EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
GLP-1 Active
Matrix: | Human Plasma |
Assay Range: | 0.977 - 1000 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
GLP-1 Total
Matrix: | Human Plasma |
Assay Range: | 4.12 - 1000 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Glucagon
Matrix: | Human Plasma |
Assay Range: | 31.3 - 2000 pg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Glucose
Matrix: | Human Plasma |
Assay Range: | 100 - 4,000 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Fluoride |
Storage Temperature (°C): | -20 |
Platform: | Enzyme assay |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Glucose
Matrix: | Human Urine |
Assay Range: | 6.25 - 250 µg/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | Enzyme assay |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Glutamate
Matrix: | CSF |
Assay Range: | 0.100 - 10.0 µg/mL |
Sample Volume: | 0.01 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Glyburide
Matrix: | Human Plasma |
Assay Range: | 1 - 400 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Glyburide
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Glyburide
Metformin
Metformin
Matrix: | Human Plasma |
Assay Range: | 2 - 150 ng/mL 20 - 1,500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Glycine
Matrix: | Human CSF |
Assay Range: | 0.0500 - 25.0 µg/mL |
Sample Volume: | 0.02 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Glycine
Matrix: | Human Plasma |
Assay Range: | 5.00 - 2,000 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
GM-CSF
Matrix: | Human Serum |
Assay Range: | 2.44 - 2,500 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ECL (MSD) (9plex) |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Granisetron
Matrix: | Human Plasma |
Assay Range: | 0.05 - 50 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiemetic |
Classification: | Drug Assays |
Granisetron
Matrix: | Human Plasma |
Assay Range: | 0.4 - 80 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antiemetic |
Classification: | Drug Assays |
Granisetron
Matrix: | Human Plasma |
Assay Range: | 0.05 - 50 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiemetic |
Classification: | Drug Assays |
Guaifenesin
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT